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The pyruvate kinase isoforms PKM1 and PKM2 are
alternatively spliced products of the PKM2 gene.
PKM2, but not PKM1, alters glucose metabolism in
cancer cells and contributes to tumorigenesis by
mechanisms that are not explained by its known
biochemical activity. We show that PKM2 gene tran-
scription is activated by hypoxia-inducible factor 1
(HIF-1). PKM2 interacts directly with the HIF-1a
subunit and promotes transactivation of HIF-1 target
genes by enhancing HIF-1 binding and p300 recruit-
ment to hypoxia response elements, whereas PKM1
fails to regulate HIF-1 activity. Interaction of PKM2
with prolyl hydroxylase 3 (PHD3) enhances PKM2
binding to HIF-1a and PKM2 coactivator function.
Mass spectrometry and anti-hydroxyproline anti-
body assays demonstrate PKM2 hydroxylation on
proline-403/408. PHD3 knockdown inhibits PKM2
coactivator function, reduces glucose uptake and
lactate production, and increases O2 consumption
in cancer cells. Thus, PKM2 participates in a positive
feedback loop that promotes HIF-1 transactivation
and reprograms glucose metabolism in cancer cells.
INTRODUCTION
The glycolytic pathway involves conversion of glucose to lactate
and the generation of ATP. Pyruvate kinase (PK), which catalyzes
the reaction of phosphoenolpyruvate (PEP) + ADP/ pyruvate +
ATP, is a key enzyme that determines glycolytic activity. PKM1
and PKM2 are alternatively spliced products of the primary
RNA transcript that contain sequences encoded by exon 9 or732 Cell 145, 732–744, May 27, 2011 ª2011 Elsevier Inc.exon 10, respectively, of the PKM2 gene (Noguchi et al., 1986).
Heterogeneous nuclear ribonucleoproteins (hnRNP) I, A1, and
A2 bind to RNA sequences encoded by exon 9 and inhibit
PKM1 mRNA splicing (David et al., 2010). The oncoprotein
c-Myc activates transcription of hnRNPI, hnRNPA1, and
hnRNPA2, resulting in preferential PKM2 isoform expression
(David et al., 2010).
Many cancer cells have increased glycolysis and lactate
production and decreased O2 consumption compared to non-
transformed cells, a phenomenon known as the Warburg effect
(Gatenby and Gillies, 2004). PKM2 promotes the Warburg effect
and tumorigenesis (Christofk et al., 2008; Hitosugi et al., 2009).
Despite intensive studies, the mechanism by which PKM2 facil-
itates lactate production and blocks mitochondrial oxidative
phosphorylation in cancer cells has remained a mystery.
Activation of hypoxia-inducible factor 1 (HIF-1), which com-
monly occurs in human cancers either as a result of hypoxia or
genetic alterations (Harris, 2002; Semenza, 2010), leads to a
switch from oxidative to glycolytic metabolism (Seagroves
et al., 2001;Wheaton andChandel, 2011). HIF-1 is a transcription
factor that consists of an O2-regulated HIF-1a subunit and a
constitutively expressed HIF-1b subunit (Wang et al., 1995). In
well-oxygenated cells, HIF-1a is hydroxylated at proline (Pro)
402 and 564 (Kaelin and Ratcliffe, 2008). Three prolyl hydroxy-
lases, PHD1–3, which require O2, Fe
2+, 2-oxoglutarate, and
ascorbate for their catalytic activity, have been shown to hydrox-
ylate HIF-1a when overexpressed (Epstein et al., 2001). PHD2 is
primarily responsible for regulating basal HIF-1a levels in cancer
cells (Berra et al., 2003). Prolyl-hydroxylated HIF-1a is bound by
the von Hippel-Lindau (VHL) tumor suppressor protein, which
recruits the Elongin C-Elongin B-Cullin 2-E3-ubiquitin-ligase
complex, leading to proteasomal degradation of HIF-1a. Under
hypoxic conditions, HIF-1a prolyl hydroxylation is inhibited,
thereby stabilizing HIF-1a protein (Kaelin and Ratcliffe, 2008).
In the nucleus, HIF-1a dimerizes with HIF-1b and binds to the
consensus nucleotide sequence 50-RCGTG-30, which is present
within the hypoxia response element (HRE) of target genes (Se-
menza et al., 1996). Hydroxylation of HIF-1a at asparagine-803,
which is catalyzed by the asparaginyl hydroxylase FIH-1 in nor-
moxic cells, blocks the binding of the transcriptional coactivator
p300 to HIF-1a (Lando et al., 2002). Under hypoxic conditions,
p300 catalyzes the acetylation of lysine residues on the
N-terminal tail of core histones at HIF-1 target genes, leading
to changes in chromatin structure that promote HIF-1-depen-
dent gene transcription (Arany et al., 1996).
HIF-1 activates transcription of genes encoding proteins that
are involved in key aspects of cancer biology, including angio-
genesis, metabolism, cell survival, invasion, and metastasis
(Harris, 2002; Melillo, 2007; Semenza, 2010). HIF-1 target genes
include those encoding: the glucose transporter GLUT1, which
increases glucose uptake; lactate dehydrogenase A (LDHA),
which converts pyruvate to lactate; and pyruvate dehydroge-
nase kinase 1 (PDK1), which inactivates pyruvate dehydroge-
nase, thereby shunting pyruvate away from the mitochondria
and inhibiting O2 consumption (Wheaton and Chandel, 2011).
In the present study, we demonstrate that PKM2 functions as a
coactivator that stimulates HIF-1 transactivation of target genes
encoding GLUT1, LDHA, and PDK1 in cancer cells. PHD3 binds
to PKM2 and stimulates its function as a HIF-1 coactivator. The
effect of PHD3 on PKM2 is dependent upon its hydroxylase
activity and the presence of two Pro residues in PKM2. PHD3
knockdown reduces glucose uptake and lactate production
and increases O2 consumption in VHL null renal cancer cells.
HIF-1 activates transcription of the genes encoding PKM2 and
PHD3, which provides a feedforward mechanism that amplifies
HIF-1-dependent metabolic reprogramming, thus providing a
molecular basis for the observed effects of PKM2 on tumor
metabolism.
RESULTS
PKM2 Is a HIF-1 Target Gene
Previous studies demonstrated that hypoxia induces PKM
mRNA expression (Semenza et al., 1994). To determine whether
mRNA encoding PKM1 or PKM2 is regulated by HIF-1, wild-type
(WT) mouse embryonic fibroblasts (MEFs) and HIF-1a knockout
(KO)MEFswere exposed to 20%or 1%O2 for 24 hr. Quantitative
real-time RT-PCR (qRT-PCR) assays with primers specific for
mouse Pkm1 or Pkm2 mRNA demonstrated that both Pkm1
and Pkm2 mRNA levels were significantly increased in response
to hypoxia in WT, but not in KO, MEFs (Figure 1A). Expression
of the known direct HIF-1 target gene Slc2a1 encoding Glut1
was similarly induced by hypoxia in WT, but not in KO, MEFs
(Figure 1A). PKM2 protein levels were increased by 1.6- and
1.7-fold in nuclear and cytosolic extracts, respectively, of
hypoxic HeLa cells (Figure 1B). Taken together, these data indi-
cate that Pkm1 andPkm2mRNAare both induced in response to
hypoxia and are regulated by HIF-1.
Analysis of the human PKM2 gene sequence revealed a
candidate HRE within the first intron containing (on the antisense
strand) the HIF-1-binding site 50-ACGTG-30 followed by a
50-CACA-30 sequence (Figure 1C), which is found in many
HREs (Fukuda et al., 2007). To determine whether HIF-1 bindsat this site, chromatin (Ch) immunoprecipitation (IP) assays
were performed in HeLa cells treated with the PHD inhibitor di-
methyloxalylglycine (DMOG) to stabilize HIF-1a protein. ChIP
with HIF-1a antibody enriched the putative HRE sequence >
70-fold compared to IP with IgG (Figure 1D). In contrast, PKM2
occupancy by HIF-2a was not above background levels (Fig-
ure 1D). These data indicate that HIF-1a, but not HIF-2a, binds
directly to the PKM2 gene.
To test whether this putative HRE in the PKM2 gene is func-
tional, a 55 bp fragment encompassing the HRE (Figure 1C)
was inserted downstream of firefly luciferase (FLuc) coding
sequences controlled by a basal SV40 promoter in the reporter
plasmid pGL2-promoter. HeLa cells were transfected with
PKM2HRE reporter and a control reporter, pSV-Renilla (in which
Renilla luciferase [RLuc] expression is driven by the SV40 pro-
moter alone), and were exposed to 20% or 1% O2 for 24 hr.
The PKM2 HRE significantly increased Fluc activity in hypoxic
HeLa cells (Figure 1E). Mutation of 50-CGT-30 to 50-AAA-30 at
the core binding site, which eliminates HIF-1 binding (Semenza
et al., 1996), significantly decreased hypoxia-induced FLuc
activity (Figure 1E). Mutation of 50-CAC-30 to 50-AAA-30 also
abolished PKM2 HRE-driven FLuc activity (Figure 1F). Transfec-
tion of either of two different HIF-1a short hairpin RNAs (shRNAs)
or either of two different HIF-2a shRNAs knocked down HIF-1a
or HIF-2a protein levels, respectively (Figure S1 available online),
but only HIF-1a shRNAs significantly reduced PKM2 HRE-
dependent FLuc activity in hypoxic HeLa cells (Figure 1G). Taken
together, these data indicate that HIF-1 binds to an HRE within
the first intron of PKM2 and directly activates its transcription.
PKM2 Interacts with HIF-1a
A large body of data indicates that HIF-1 and PKM2 contribute to
the Warburg effect and tumor growth (Christofk et al., 2008;
Gatenby and Gillies, 2004; Melillo, 2007; Semenza, 2010). The
presence of PKM2 in the nucleus (Figure 1B) suggested the
intriguing possibility that PKM2 may enhance glucose metabo-
lism by regulating HIF-1. To test this hypothesis, we investigated
whether HIF-1a interacts with PKM2. A stable isotope labeling by
amino acids in cell culture (SILAC)-based quantitative proteomic
screen (Luo et al., 2010) revealed that PKM2 preferentially bound
to a GST-HIF-1a (531–826) fusion protein containing amino acid
residues 531–826 of HIF-1a as compared to GST alone (Fig-
ure 2A), suggesting that PKM2 is a novel HIF-1a-interacting
protein. To confirm this proteomic finding, co-IP assays were
performed in HeLa cells exposed to 1% O2 for 24 hr. Endoge-
nous PKM2 was specifically precipitated by anti-HIF-1a anti-
body, but not by control IgG (Figure 2B). To determine whether
PKM2 specifically interacts with HIF-1a in the nucleus, HeLa
cells were transfected with an expression vector encoding V5
epitope-tagged PKM2, exposed to 1% O2 for 24 hr to induce
HIF-1a expression, and nuclear extracts were prepared.
PKM2-V5 was efficiently coimmunoprecipitated with HIF-1a
(Figure 2C). These data demonstrate that PKM2 physically inter-
acts with HIF-1a in the nuclei of hypoxic human cancer cells.
To localize sites of interactionwith PKM2,we utilized a panel of
GST-HIF-1a fusion proteins. In vitro GST pull-down assays re-
vealed that PKM2-V5 strongly bound to GST-HIF-1a (81–200),
(201–329), and (331–427) and also associated weakly withCell 145, 732–744, May 27, 2011 ª2011 Elsevier Inc. 733
Figure 1. HIF-1 Regulates Hypoxia-Induced
Expression of PKM1 and PKM2
(A) qRT-PCR analysis of Pkm1, Pkm2, and Slc2a1
mRNA in wild-type (WT) and HIF-1a knockout (KO)
mouse embryo fibroblasts (MEFs) exposed to
20% or 1% O2 for 24 hr (mean ± SEM, n = 3–5).
***p < 0.001 versus 20% O2.
###p < 0.001 versus
WT MEFs.
(B) Immunoblot assays of HIF-1a, PKM2, histone
H3, and a-tubulin protein in nuclear and cytosolic
lysates prepared from HeLa cells exposed to 20%
or 1% O2 for 24 hr. The intensity of PKM2 was
quantified by densitometry and normalized to 20%
O2 (mean ± SEM, n = 3–4). *p < 0.05, **p < 0.01
versus 20% O2.
(C) Nucleotide sequence of the hypoxia response
element (HIF-1-binding site 50-ACGTG-30 and
50-CACA-30 site shown in red) within intron 1 of the
human PKM2 gene. The transcription initiation site
is designated +1. Exons and intron are not drawn
to scale.
(D) Chromatin was precipitated from DMOG-
treated HeLa cells (4 hr) with antibodies against
HIF-1a, HIF-2a, or IgG and was analyzed by qPCR
(mean ± SEM, n = 4–5). *p < 0.05 versus IgG.
(E and F) HeLa cells were cotransfected with
pGL2p control (CON), pGL2p-WT PKM2 HRE
(wtHRE), or pGL2p mutant PKM2 HRE (mutHRE)
with CGT/AAA (E) or CAC/AAA (F), and pSV-
Renilla and were exposed to 20% or 1% O2 for
24 hr. The ratio of FLuc:RLuc activity was nor-
malized to CON at 20% O2 (mean ± SEM, n = 4).
#p < 0.05, ###p < 0.001 versus CON; ***p < 0.001
versus wtHRE.
(G) HeLa cells were transfected with: vector en-
coding a short hairpin (sh) RNA targeting HIF-1a,
HIF-2a, or a scrambled control (SC); pGL2p-
wtHRE; and pSV-Renilla. The cells were exposed
to 20% or 1% O2 for 24 hr. The ratio of FLuc:RLuc
activity was normalized
to shSC at 20% O2
(mean ± SEM, n = 4).
***p < 0.001 versus shSC.
See also Figure S1. To
hear anauthor explain this
figure, refer to Audio S1.GST-HIF-1a (1–80), (432–528), and (531–826) (Figure 2D). The
lack of interaction of PKM2-V5withGSTconfirmed the specificity
of binding (Figure 2D). These data indicate that PKM2 binds to
multiple domains of HIF-1a in vitro. We further mapped PKM2
binding within the transactivation domain of HIF-1a and found
thatPKM2-V5mainlybound toGST-HIF-1a (575–786) (Figure2E),
which encodes an inhibitory domain associatedwith regulation of
the HIF-1a transactivation domain (Jiang et al., 1997).
PKM2 Regulates HIF-1 Transcriptional Activity
To test whether PKM2 regulates HIF-1 transcriptional activity,
HeLa cells were cotransfected with: HIF-1 reporter plasmid
p2.1, which contains an HRE from the human ENO1 gene up-
stream of SV40 promoter and FLuc coding sequences (Semenza
et al., 1996); pSV-Renilla; and empty vector (EV) or PKM2-V5734 Cell 145, 732–744, May 27, 2011 ª2011 Elsevier Inc.expression vector. Transfected cells were exposed to 20%
or 1% O2 for 24 hr. PKM2-V5 significantly increased HIF-1
transcriptional activity in a concentration-dependent manner
(Figure 3A). Conversely, knockdown of endogenous PKM2
expression by shRNA (shPKM2) significantly reducedHIF-1 tran-
scriptional activity in hypoxic HeLa cells (Figure 3B). Similar
results were observed in Hep3B hepatoblastoma cells (Figures
S2A and S2B). These data indicate that PKM2 promotes HIF-1
transcriptional activity in human cancer cells.
To determine whether PKM2 influences HIF-1 transcriptional
activity by increasingHIF-1a protein levels, HeLa cellswere trans-
fected with EV or PKM2-V5 expression vector and exposed to
20% or 1% O2 for 4 hr. PKM2-V5 expression did not affect
HIF-1a or HIF-1b protein levels (Figure 3C). PKM2 knockdown
also failed to alter protein levels of HIF-1a or HIF-1b in HeLa cells
Figure 2. PKM2 Interacts with HIF-1a
(A) GST pull-down assays were performed with
GST or GST-HIF-1a (531–826) and lysate pre-
pared from HEK293 cells grown in media con-
taining light isotopes (12C6-
14N2-Lys and
12C6-
14N4-Arg) or heavy isotopes (
13C6-
15N2-Lys
and 13C6-
15N4-Arg), respectively. The precipitated
proteins were analyzed by Q-TOF mass spec-
trometry (Luo et al., 2010). The mass spectrum of
a tryptic PKM2 peptide is shown. Monoisotopic
peaks derived from PKM2 bound to GST-HIF-1a
(531–826) are 4 Da greater in their mass/charge
ratio (m/z) and have higher relative intensity
compared to the corresponding peaks due to
nonspecific binding of PKM2 to GST.
(B) Co-IP was performed in HeLa cells exposed to
1% O2 for 24 hr.
(C) Co-IP was performed using nuclear lysates
(NL) prepared from HeLa cells transfected with
PKM2-V5 vector and exposed to 1% O2 for 24 hr.
(D and E) GST pull-down assays were performed
with GST or GST fusion protein containing the
indicated amino acid residues of HIF-1a (top)
and whole-cell lysates (WCLs) from HeLa
cells expressing PKM2-V5. bHLH, basic helix-
loop-helix; PAS, Per-
ARNT-Sim; TAD, trans-
activation domain; ID,
inhibitory domain.
To hear an author explain
this figure, refer to
Audio S2.(Figure3D).Thesedata ruleoutaneffectonHIF-1aprotein stability
as the cause of PKM2-stimulated HIF-1 transcriptional activity.
To directly investigate the effect of PKM2 on HIF-1a transacti-
vation domain function, we employed a reporter assay utilizing
expression vector GalA, which encodes the GAL4 DNA-binding
domain fused to the HIF-1a transactivation domain (531–826),
and reporter plasmid pG5E1bLuc, which contains five GAL4-
binding sites and a TATA box upstream of FLuc coding
sequences (Jiang et al., 1997). HeLa cells were cotransfected
with GalA or GalO (encoding GAL4 DNA-binding domain alone);
pG5E1bLuc; pSV-Renilla; and EV or PKM2-V5 expression
vector. PKM2-V5 significantly increased GalA transcriptional
activity in HeLa cells exposed to 20% or 1% O2 for 24 hr (Fig-
ure 3E). GalA protein levels were not affected by PKM2-V5
(data not shown). PKM2-V5 did not induce FLuc activity when
cotransfected with GalO (Figure 3E), indicating that PKM2
specifically stimulates HIF-1a transactivation domain function.
Knockdown of endogenous PKM2 significantly decreased
GalA activity in HeLa cells (Figure 3F). PKM2 also regulated
GalA activity in Hep3B cells (Figures S2C and S2D). Taken
together, these data indicate that PKM2 directly stimulates
HIF-1a transactivation domain function.
To determine whether PKM2 enzymatic activity is required to
stimulate HIF-1a transactivation, we expressed catalytically
inactive PKM2(K270M), which is deficient in phosphoryl transfer
from PEP to ADP (Dombrauckas et al., 2005). p2.1 reporter
assays demonstrated that PKM2(K270M) increased HIF-1 tran-
scriptional activity in HeLa cells, similar to WT PKM2 (Figure 3G).GalA activity was also stimulated by catalytically inactive
PKM2(K270M) (Figure 3H). We conclude that stimulation of
HIF-1a transactivation by PKM2 is independent of its catalytic
activity as a glycolytic enzyme.
We asked whether PKM2 can also regulate HIF-2 transcrip-
tional activity. PKM2-V5 expression significantly enhanced
p2.1 transcriptional activity in HeLa cells cotransfected with
HIF-2a expression vector (Figure S2E). Co-IP assays using
anti-HIF-2a antibody demonstrated that HIF-2a interacted with
PKM2-V5 in hypoxic cells (Figure S2F). Thus, PKM2 also
promotes HIF-2 transcriptional activity.
PKM1 is an alternative splice product of the PKM2 gene that
does not mediate the Warburg effect (Christofk et al., 2008). We
testedwhetherPKM1also regulatesHIF-1 transcriptional activity.
PKM1-V5 protein levels were comparable to PKM2-V5 protein
levels in HeLa cells (Figure S2G). However, PKM1-V5 failed to
activate HIF-1-dependent p2.1 transcriptional activity (Figure 3I)
or GalA-dependent transactivation (Figure S2H) in HeLa cells.
In vitro binding assays revealed that FLAG-HIF-1a(531–826)
strongly bound to a GST-E10 fusion protein, which contains the
PKM2-specific amino acid residues encoded by PKM2 exon 10,
but did not bind to GST and bound very weakly to GST-E9 fusion
protein, which contains the residues encoded by PKM1-specific
exon 9 (Figure 3J). Taken together, these data indicate that
PKM2, but not PKM1, stimulates HIF-1 transcriptional activity
and that physical association between the HIF-1a transactivation
domain and thealternatively spliceddomain of PKM2 is critical for
stimulation of HIF-1a transactivation.Cell 145, 732–744, May 27, 2011 ª2011 Elsevier Inc. 735
Figure 3. PKM2 Promotes HIF-1 Transacti-
vation
(A, B, G, and I) HeLa cells were transfected with
p2.1, pSV-Renilla, and empty vector (EV) or the
indicated expression vector and were exposed to
20% or 1% O2 for 24 hr. The ratio of FLuc:RLuc
activity was normalized to EV (A, G, and I) or
shSC (B) at 20%O2 (mean ±SEM, n = 4). *p < 0.05,
**p < 0.01, ***p < 0.001 versus EV or shSC.
(C) Immunoblot assays of HIF-1a, HIF-1b, PKM2-
V5, and actin in HeLa cells transfected with EV or
PKM2-V5 expression vector (M2) and exposed to
20% or 1% O2 for 4 hr.
(D) HeLa cells were transduced with a retrovirus
encoding shSC or two retroviruses encoding
different shRNAs targeting PKM2 (shM2) and were
exposed to 20% or 1% O2 for 4 hr. WCLs were
subjected to immunoblot assays.
(E, F, and H) HeLa cells were transfected with GalA
or GalO, pG5E1bLuc, pSV-Renilla, and the indi-
cated expression vector and were exposed to
20% or 1% O2 for 24 hr. The ratio of FLuc:RLuc
activity was normalized to GalO (E and F) or EV (H)
at 20% O2 (mean ± SEM, n = 4). *p < 0.05, **p <
0.01, ***p < 0.001 versus EV or shSC.
(J) GST pull-down assays were performed with
GST, GST-E9, or GST-
E10 andWCLs fromHeLa
cells expressing FLAG-
HIF-1a (531–826).
See also Figure S2. To
hear anauthor explain this
figure, refer to Audio S3.PHD3 Potentiates the Effect of PKM2
on HIF-1a Transactivation
Analysis of the amino acid sequence of the alternatively spliced
domain of PKM2 (Figure S3A) revealed a match with the prolyl
hydroxylation motif LXXLAP, which is present in all vertebrate
HIF-1a and HIF-2a isoforms (Epstein et al., 2001). This prolyl
hydroxylation motif is not present in PKM1 (Figure S3A). We736 Cell 145, 732–744, May 27, 2011 ª2011 Elsevier Inc.hypothesized that hydroxylation of
PKM2 at Pro-403 may regulate HIF-1a
binding and stimulation of transactivation.
To test this hypothesis, we first investi-
gated prolyl hydroxylation of PKM2 by
LTQ Orbitrap Velos mass spectrometry.
GST-E10 fusion protein was purified
from bacteria and incubated for 1 hr with
cell lysate that was supplemented with
PHD cofactors (FeCl2, 2-oxoglutarate,
and ascorbate). Mass spectrometry anal-
ysis revealed hydroxylation of Pro-403 as
well as Pro-408 (Figure 4A). Prolyl hydrox-
ylation of PKM2 was further verified using
an antibody raised against hydroxyproline
(Pro-OH). The anti-Pro-OH antibody pref-
erentially bound to WT FLAG-HIF-1a as
compared to double mutant (DM) FLAG-HIF-1a (P402/564A) in which both hydroxylatable Pro residues
have been changed to alanine (Figure 4B). These results vali-
dated the selectivity of the anti-Pro-OH antibody. The residual
antibody binding to FLAG-HIF-1a(DM) may represent low-
affinity binding to nonhydroxylated Pro residues or spontaneous
(noncatalytic) oxidation of other Pro residues in HIF-1a(DM).
Analysis of immunoprecipitated PKM2-V5 protein revealed that
PKM2-V5 was prolyl hydroxylated in HeLa cells cultured at 20%
O2 (Figure 4C). Remarkably, prolyl hydroxylation of PKM2-V5
was also detected in HeLa cells cultured at 1% O2. In contrast,
PKM1-V5 was not hydroxylated (Figure 4C), again demon-
strating the selectivity of the antibody. Endogenous PKM2 was
also hydroxylated in hypoxic HeLa cells (1% O2), but hydroxyl-
ation was reduced when cells was exposed to near-anoxic
conditions (<0.1% O2) for 4 hr (Figure 4D). Double mutation of
Pro-403/408 to alanine significantly reduced Pro-OH antibody
binding by 50% (Figure 4E and Figure S3B). Together, these
data indicate that PKM2 is hydroxylated at Pro-403/408 within
the domain that is not present in PKM1.
To investigate whether prolyl hydroxylation of PKM2 regulates
HIF-1a transactivation, we compared the effect of WT PKM2-V5
and PKM2(P403/408A)-V5 in reporter assays. The p2.1 andGalA
assays revealed that double mutation of Pro-403/408 signifi-
cantly reduced PKM2-mediated HIF-1 transactivation in HeLa
cells (Figures 4F and 4G) despite the fact that PKM2(P403/
408A)-V5 was detected in the nucleus at levels similar to WT
PKM2-V5 (Figure S3C). Co-IP assays revealed that doublemuta-
tion of Pro-403/408 markedly reduced the binding of PKM2-V5
to endogenous HIF-1a in hypoxic cells (Figure 4H). Taken
together, these data suggest that prolyl hydroxylation of PKM2
enhances HIF-1a:PKM2 interaction, thereby promoting HIF-1a
transactivation.
To determine whether prolyl hydroxylase activity stimulates
HIF-1 transactivation, HeLa cells were transfected with PKM2-V5
vector and treated with the hydroxylase inhibitor DMOG or
vehicleDMSO for 4 hr. DMOG largely inhibitedprolyl hydroxylation
of PKM2-V5 (Figure 4I). PKM2-V5 binding to FLAG-HIF-1a(DM)
was also reduced by DMOG treatment of HeLa cells (Figure 4J),
thereby eliminating any potential effects of DMOG on prolyl
hydroxylation of HIF-1a. To eliminate any potential effects of
DMOG that were due to inhibition of asparaginyl hydroxylation
by FIH-1, reporter assays were performed using GalA(N803A).
DMOG significantly decreased basal GalA(N803A) activity as well
asPKM2-enhancedGalA(N803A) activity inHeLacells (Figure 4K).
These results indicate that inhibition of prolyl hydroxylase activity
impairs HIF-1a transactivation.
Next, we investigated which PHD isoform is involved in the
hydroxylation of PKM2. PHD3 interacted with purified GST-
PKM2 in vitro (Figure S4A) and coimmunoprecipitated with
PKM2-V5 from transfected cells (Figure 5A). Moreover, PHD3
specifically bound to GST-E10, but not to GST or GST-E9 (Fig-
ure 5B), suggesting that PHD3 may mediate prolyl hydroxylation
of PKM2. Immunoblot assays indicated that prolyl hydroxylation
of PKM2-V5 was inhibited by 50% in HeLa cells transduced with
retrovirus encoding PHD3 shRNA (shPHD3) (Figure 5C), which
was similar to the effect of exposing cells to near-anoxic condi-
tions (Figure 4D) or mutation of P403/408A (Figure 4E). Hypoxia
dramatically increased PHD3 levels, which compensated for the
decreased hydroxylase activity at 1% O2 (Epstein et al., 2001),
resulting in similar levels of prolyl hydroxylation of PKM2 in cells
incubated at 20% and 1% O2 for 24 hr (Figure 5C). Overexpres-
sion of PHD3 dramatically reduced FLAG-HIF-1a levels in
hypoxic HeLa cells (Figure S4B), confirming that PHD3 retains
hydroxylase activity at 1% O2. PKM2-V5 protein levels were
not altered by shPHD3 (Figure 5C).To examine whether PHD3 potentiates PKM2-mediated
HIF-1a transactivation, we generated a mutant GalA(P564A)
construct so that only PKM2 would be a target for prolyl hydrox-
ylation. GalA(P564A) assays demonstrated that PHD3 increased
HIF-1a transactivation in RCC4 renal carcinoma cells, which
constitutively express HIF-1a under nonhypoxic conditions due
to VHL loss of function, whereas catalytically inactive
PHD3(H135A/D137A) failed to increase HIF-1a transactivation
(mutPHD3, Figure 5D). PHD3 overexpression in RCC4 cells
enhanced HIF-1a transactivation mediated by WT PKM2, but
not PKM2(P403/408A) (mutPKM2, Figure 5D). PHD3, but not
PHD3(H135A/D137A), also potentiated PKM2-mediated HIF-1a
transactivation in HeLa cells (Figure S4C). Thus, the ability of
PHD3 to stimulate PKM2 coactivator function is dependent
upon PHD3 catalytic activity and Pro residues (putative hydrox-
ylation sites) in the PKM2-specific domain.
PHD3 knockdown significantly reduced HIF-1a transactivation
inhypoxicHeLacells (Figure5E).PHD3overexpressionenhanced
the interaction of PKM2-V5 with FLAG-HIF-1a(DM) in transfected
HeLa cells (Figure 5F) but did not stimulate the interaction
between PKM2(P403/408A)-V5 and FLAG-HIF-1a(DM) (Fig-
ure S4D). Conversely, PHD3 knockdown decreased PKM2-V5
interaction with endogenous HIF-1a in hypoxic HeLa cells (Fig-
ure 5G). The data presented in Figure 5 strongly suggest that
PHD3 induces hydroxylation of PKM2 at Pro-403/408, thereby
increasing the interaction of PKM2 with HIF-1a and potentiating
PKM2-mediated HIF-1a transactivation.
We further investigated whether other PHDs regulate PKM2.
FLAG-PHD1 failed to interact with PKM2-V5 (Figure S4E).
Although PHD2 coimmunoprecipitated with PKM2 (Figure S4F),
PHD2 knockdown failed to affect prolyl hydroxylation of PKM2
in HeLa cells transduced with lentivirus encoding an shRNA
that effectively reduced PHD2 protein levels (Figure 5C). FLAG-
PHD2 overexpression also had no effect on HIF-1a transactiva-
tion domain function (Figure S4G). Therefore, PHD3 is a specific
regulator of PKM2-stimulated HIF-1 transcriptional activity.
PKM2 Enhances HIF-1 Binding to the HREs
of Target Genes
To determine whether PKM2 enhances HIF-1 DNA-binding
activity,HeLacellswere transfectedwith vector encoding scram-
bled control shRNA (shSC) or shPKM2andwere exposed to 20%
or 1%O2 for 4 hr. ChIP assays demonstrated that, relative to IgG
background signals, HIF-1a occupancywas detected at theHRE
of HIF-1 target genes, including LDHA and PDK1, but not at the
non-HIF-1 target gene RPL13A, in nonhypoxic HeLa cells trans-
fected with shSC vector (Figure 6A and Figure S5A). Hypoxia
significantly increased HIF-1a occupancy at the LDHA and
PDK1 HREs. The lack of HIF-2a occupancy on HIF-1-selective
target genes LDHA and PDK1 demonstrated the specificity of
theassay (Figure 6AandFigureS5A).Knockdownof endogenous
PKM2 significantly reduced HIF-1a occupancy at the LDHA and
PDK1 HREs in hypoxic HeLa cells, but not at the RPL13A gene
(Figure 6A and Figure S5A), indicating that PKM2 specifically
enhances HIF-1a binding at the HRE of target genes. HIF-1b
occupancy at the PDK1 and LDHA genes, but not at the
RPL13A gene, was also significantly reduced by PKM2 knock-
down in hypoxic HeLa cells (Figure 6B and Figure S5B). PKM2Cell 145, 732–744, May 27, 2011 ª2011 Elsevier Inc. 737
Figure 4. Prolyl Hydroxylation of PKM2 Stimulates HIF-1 Transactivation
(A) GST-E10 was incubated with WCLs to induce hydroxylation, and tryptic peptides were analyzed by mass spectrometry. The fragmentation spectrum
of 401LAPITSDPTEATAVGAVEASFK422 revealed the presence of peptides with hydroxylation of Pro-403 or Pro-408.
(B) HEK293 cells were transfected with WT FLAG-HIF-1a or double-mutant (DM) FLAG-HIF-1a(P402A/P564A) and were treated with the proteasome inhibitor
MG132 (10 mM) for 4 hr. IP was performed with anti-FLAG antibody, followed by immunoblot assay. The intensity of hydroxylated FLAG-HIF-1awas quantified by
densitometry and normalized to WT.
(C) HeLa cells were transfected with vector encoding PKM2-V5 or PKM1-V5 andwere exposed to 20%or 1%O2 for 24 hr. IPwas performedwith anti-V5 agarose,
followed by immunoblot assay.
(D) HeLa cells were exposed to 1%or < 0.1%O2 for 4 hr. IP was performed with anti-PKM2 antibody, followed by immunoblot assay. The
intensity of hydroxylated PKM2 was quantified by densitometry and normalized to 1% O2.
(E) HeLa cells were transfected with vector encoding WT PKM2-V5 or PKM2(P403/408A)-V5 and were exposed to 20% or 1% O2 for
24 hr. IP was performed with anti-V5 agarose, followed by immunoblot assay.
(F and G) HeLa cells were cotransfected with p2.1 (F) or GalA(P564A) and pG5E1bLuc (G); pSV-Renilla; and the indicated expression
vector and were exposed to 20%or 1%O2 for 24 hr. The ratio of FLuc:RLuc activity was normalized to EV at 20%O2 (mean ±SEM, n = 4).
***p < 0.001 versus EV; #p < 0.05, ###p < 0.001 versus PKM2(WT).
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Figure 5. PHD3 Stimulates the Coactivator
Function of PKM2
(A) Co-IP was performed in HeLa cells co-
transfected with PKM2-V5 and PHD3 vectors.
(B) GST pull-down assays were performed with
purified GST, GST-E9, or GST-E10 and WCLs
from HeLa cells exposed to 1% O2 for 24 hr.
(C) HeLa-shSC, HeLa-shPHD3-704, and HeLa-
shPHD2 cells were transfected with PKM2-V5
vector and exposed to 20% or 1% O2 for 24 hr.
IP was performed with anti-V5 agarose, followed
by immunoblot assay. Hydroxylated PKM2-V5
was quantified by densitometry and normalized to
total immunoprecipitated PKM2-V5 (mean ± SEM,
n = 3). **p < 0.01, ***p < 0.001 versus shSC.
(D) RCC4 cells were cotransfected with Gal-
A(P564A) vector, pG5E1bLuc, pSV-Renilla, and
the indicated expression vector for 24 hr. The ratio
of FLuc:RLuc activity was normalized to EV
(mean ± SEM, n = 4). *p < 0.05; **p < 0.01;
***p < 0.001. mutPHD3, PHD3(H135A/D137A);
mutPKM2, PKM2(P403/408A).
(E) HeLa cells were cotransfected with GalA
(P564A) vector, pG5E1bLuc, pSV-Renilla, and the
indicated expression vector and were exposed to
20% or 1% O2 for 24 hr. The ratio of FLuc:RLuc
activity was normalized to shSC at 20% O2
(mean ± SEM, n = 4). ***p < 0.001 versus shSC.
(F) Co-IP was performed in HeLa cells co-
transfected with vector encoding double mutant
(DM) FLAG-HIF-1a(P402A/P564A), EV or PHD3,
and PKM2-V5.
(G) Co-IP was performed in HeLa cells cotrans-
fected with vectors en-
coding PKM2-V5 and
either shSC or shPHD3
and exposed to 1% O2
for 24 hr.
See also Figure S4. To
hear anauthor explain this
figure, refer to Audio S5.knockdown had no effect on HIF-1a or HIF-1b protein levels in
HeLa cells (Figure 3D and Figure S5D). Moreover, neither
PKM2-V5 overexpression nor PKM2 knockdown affected HIF-
1a/HIF-1b dimerization in hypoxic HeLa cells (Figures S5C and
S5D). In contrast to LDHA and PDK1, VEGF gene transcription
is regulated by both HIF-1 and HIF-2, and occupancy of the
VEGF HRE by both HIF-1a and HIF-2a was significantly
decreased by PKM2 knockdown (Figure S5E). Taken together,
these data indicate that PKM2 enhances HIF binding to HREs
within target genes, thereby promoting transactivation.
Next, we determined whether PKM2 is recruited to the HRE of
HIF-1 target genes. ChIP assays demonstrated PKM2 occu-(H) Co-IP was performed in HeLa cells transfected with vector encoding WT PKM2
(I) HeLa cells were transfected with PKM2-V5 vector and were treated with DMSO
immunoblot assay.
(J) Co-IP was performed in HeLa cells cotransfected with FLAG-HIF-1a(DM) and
(K) HeLa cells were cotransfected with GalA(N803A) vector, pG5E1bLuc, pSV-R
24 hr. The ratio of FLuc:RLuc activity was normalized to EV + DMSO (mean ± SE
See also Figure S3. To hear an author explain this figure, refer to Audio S4.pancy at the HRE of HIF-1 target genes LDHA and PDK1, but
not at the RPL13A gene in hypoxic HeLa cells (Figure 6C and
Figure S5F). PHD3 occupancy at the HRE of LDHA and PDK1
genes was also detected in hypoxic HeLa cells (Figure 6D and
Figure S5G). These data indicate that PKM2 and PHD3 both
colocalize with HIF-1a at the HRE of HIF-1 target genes.
PKM2 Stimulates p300 Recruitment to the HRE
of HIF-1 Target Genes
The histone acetyltransferase p300 is a coactivator that regulates
HIF-1 transactivation (Arany et al., 1996). We investigated
whether PKM2 contributes to p300 recruitment to the HRE of-V5 or PKM2(P403/408A)-V5 and exposed to 1%O2 for 4 hr.
or DMOG (100 mM) for 4 hr. IP was performedwith anti-V5 agarose, followed by
PKM2-V5 vectors and treated with DMSO or DMOG for 4 hr.
enilla, and EV or PKM2-V5 vector and were treated with DMSO or DMOG for
M, n = 4). *p < 0.05 versus EV; #p < 0.05, ##p < 0.01 versus DMSO.
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Figure 6. PKM2 Enhances HIF-1 Binding and p300 Recruitment to HREs
(A) HeLa cells were transfected with shSC or shPKM2-#1 vector and were exposed to 20% or 1%O2 for 4 hr. ChIP assays were performed with IgG, anti-HIF-1a,
or anti-HIF-2a antibody (mean ± SEM, n = 4). #p < 0.05 versus shSC-20% O2; *p < 0.05 versus shSC-1% O2.
(B) HeLa cells were transfected with shSC or shPKM2-#1 vector and were exposed to 1% O2 for 4 hr. ChIP assays were performed with IgG or anti-HIF-1b
antibody (mean ± SEM, n = 3). #p < 0.05 versus IgG; *p < 0.05 versus shSC.
(C and D) HeLa cells were exposed to 1% O2 for 24 hr. ChIP assays were performed with IgG, anti-PKM2 (C) or anti-PHD3 (D) antibody (mean ± SEM, n = 3).
**p < 0.01, ***p < 0.001 versus IgG.
(E) Co-IP was performed in HeLa cells transfected with PKM2-V5 vector for 24 hr.
(F) HeLa cells expressing shSC or shPKM2-#1 were exposed to 20% or 1% O2 for 24 hr. ChIP assays were performed with IgG or anti-
p300 antibody (mean ± SEM, n = 3). *p < 0.05, **p < 0.01 versus shSC; ###p < 0.001 versus shSC-20% O2.
(G) HeLa cells were transfectedwith shSC or shPKM2-#1 vector and exposed to 1%O2 for 24 hr. ChIP assayswere performedwith IgG or
anti-acetylated H3K9 (H3K9-ac) antibody (mean ± SEM, n = 3). **p < 0.01 versus shSC.
(H) Immunoblot assays of total H3K9-ac, histone H3, and PKM2 in HeLa cells transfected with shSC or shPKM2-#1 vector and exposed
to 1% O2 for 24 hr.
See also Figure S5. To hear an author explain this figure, refer to Audio S6.HIF-1 target genes. Co-IP assays demonstrated that PKM2-V5
physically interacted with p300 in HeLa cells (Figure 6E). ChIP
assays revealed that p300 bound to the LDHAHRE, and hypoxia740 Cell 145, 732–744, May 27, 2011 ª2011 Elsevier Inc.increased p300 occupancy in HeLa cells transfected with shSC
vector (Figure 6F). However, PKM2 knockdown significantly
reduced p300 occupancy at the LDHA HRE in nonhypoxic and
Figure 7. PKM2 and PHD3 Promote HIF-1-
Dependent Glycolytic Metabolism
(A) qRT-PCR analysis of indicated mRNAs in HeLa
cells transfected with shSC or shPKM2-#1 vector
and exposed to 20% or 1% O2 for 24 hr (mean ±
SEM, n = 4). *p < 0.05, **p < 0.01, ***p < 0.001.
(B) HeLa cells were transduced with shSC or
shPKM2-#1 and shPKM2-#2 retrovirus and were
exposed to 20% or 1% O2 in the absence or
presence of digoxin (100 nM) for 24 hr. Levels of
the indicated protein were determined by immu-
noblot assay, quantified by densitometry, and
normalized to actin (mean ± SEM, n = 4). *p < 0.05,
***p < 0.001.
(C) qRT-PCR analysis of indicated mRNAs in HeLa
cells transduced with shSC or shPHD3-704
retrovirus and exposed to 20% or 1% O2 for
24 hr (mean ± SEM, n = 3–4). ###p < 0.001 versus
shSC-20% O2; **p < 0.01, ***p < 0.001 versus
shSC-1% O2.
(D–F) RCC4 cells were transduced with shSC or
shPHD3-704 retrovirus. Glucose was measured in
lysates and normalized to total cellular protein
amount (mean ± SEM, n = 3; D); lactate was
measured in the culture media and normalized to
cell number (mean ± SEM, n = 3; E); O2 con-
sumption rate (OCR) was measured and normal-
ized to cell number (mean ± SEM, n = 4–8; F).
*p < 0.05, **p < 0.01, ***p < 0.01 versus shSC.
(G) PKM2 is prolyl hydroxylated by PHD3 and
interacts with HIF-1a and p300, thereby
enhancing HRE occupancy by HIF-1 and p300
and increasing histone acetylation.
(H) Feedforward mechanism for HIF-1 activity.
HIF-1 activates transcription of genes encoding
PHD3 and PKM2, which interact with HIF-1a
to stimulate transactivation of target genes en-
coding GLUT1, LDHA,
PDK1, and other meta-
bolic enzymes that
mediate the Warburg
effect in cancer cells.
See also Figure S6. To
hear anauthor explain this
figure, refer to Audio S7.hypoxic HeLa cells (Figure 6F). Levels of histone H3 acetylated
at lysine-9 (H3K9-ac) at the LDHA HRE were significantly
decreased in hypoxicHeLa cells transfectedwith shPKM2 vector
(Figure 6G), whereas PKM2 knockdown did not affect H3K9-ac
levels at the RPL13A gene (Figure 6G) or total histone H3
occupancy at the LDHA or RPL13A gene (Figures S5H and
S5I). PKM2 knockdown also had no effect on total cellular
H3K9-ac or H3 levels (Figure 6H). These data indicate that
PKM2 specifically enhances p300 recruitment to the HRE of
HIF-1 target genes and promotes H3K9 acetylation, which is
an epigenetic modification that is associated with gene
transcription.
PKM2 and PHD3 Regulate HIF-1-Dependent Metabolic
Reprogramming
To determine whether PKM2 regulates HIF-1-dependent
expression of genes encoding proteins in the glycolytic pathway,HeLa cells were transfected with shSC or shPKM2 vector and
exposed to 20% or 1% O2 for 24 hr. qRT-PCR assays revealed
that shPKM2 significantly decreased expression of the glycolytic
genes LDHA, PDK1, SLC2A1, and HK1 and the angiogenesis
gene VEGF in HeLa cells, whereas expression of the non-HIF-1
target genes COX4I1, LDHB, and RPL13Awas not affected (Fig-
ure 7A and Figure S6A). LDHA, PDK1, and GLUT1 protein levels
were also significantly reduced in HeLa cells transduced with
shPKM2 retrovirus, which was comparable to the effect of treat-
ment with digoxin (Figure 7B and Figure S6B), a drug that inhibits
HIF-1a synthesis (Zhang et al., 2008). Thus, PKM2 coactivates
expression of HIF-1 target genes encoding glucose transporter
and glycolytic enzymes.
To determine whether PHD3 activity stimulates expression of
HIF-1 target genes, we performed qRT-PCR assays, which
demonstrated that LDHA, PDK1, and SLC2A1 gene expression
was significantly decreased in HeLa cells transduced withCell 145, 732–744, May 27, 2011 ª2011 Elsevier Inc. 741
shPHD3 retrovirus, compared to cells transduced with shSC
retrovirus (Figure 7C). However, expression of COX4I1 and
RPL13A, which are not regulated by HIF-1, was not affected
by PHD3 knockdown (Figure 7C). HIF-1a levels were not altered
in PHD3 knockdown HeLa cells (Figure S6C), indicating that
reduced HIF-1 transactivation accounts for the inhibition of
HIF-1 target gene expression in PHD3 knockdown cells.
LDHA, PDK1, and GLUT1 mRNA and protein levels were also
reduced by PHD3 knockdown in RCC4 cells (Figures S6D and
S6E). Consistent with altered expression of glucose transporters
and glycolytic enzymes, intracellular glucose and extracellular
lactate levels were significantly decreased in RCC4 cells trans-
duced with shPHD3 retrovirus, compared to cells transduced
with shSC retrovirus (Figures 7D and 7E). PHD3 knockdown
significantly increased the basal O2 consumption rate (OCR)
and maximal OCR stimulated by 2,4-dinitrophenol (DNP,
20 mM) in RCC4 cells (Figure 7F). Similar results on glucose
uptake, lactate production, and OCR were also observed in
RCC4 cells transduced with lentivirus encoding a different
PHD3 shRNA (Figures S6F–S6H), which completely knocked
down PHD3 protein levels (Figure S6I). Thus, PHD3 knockdown,
which inhibits PKM2 coactivator function (Figure 5D) and PKM2
binding to HIF-1a (Figure 5G), also reduces glucose uptake and
lactate production and increases O2 consumption in cancer
cells.
DISCUSSION
In the present study, we demonstrate that PKM2 is a direct HIF-1
target gene and that expression of PKM1 and PKM2, the alterna-
tive isoenzymes of the PKM2 gene, is controlled by HIF-1.
Remarkably, PKM2 interacts with HIF-1a within multiple
domains. PKM2 binding to the transactivation domain of
HIF-1a stimulates HIF-1 transcriptional activity. Although
PKM2 also binds strongly to the PAS domain of HIF-1a, it does
not affect the two known biological functions of the PAS domain,
HIF-1a/HIF-1b dimerization and HIF-1a protein stability. ChIP
data indicate that PKM2 stabilizes binding of HIF-1 to DNA,
and further studies are required to determine whether this prop-
erty is dependent upon interaction of PKM2with the PAS domain
of HIF-1a.
PKM2 localizes in the nucleus, is recruited with HIF-1 to HREs,
and enhances HIF-1 occupancy, p300 recruitment, and H3K9
acetylation, thereby promoting transactivation of genes encod-
ing glucose transporters and glycolytic enzymes in cancer cells
(Figure 7G). In contrast, PKM1 does not regulate HIF-1 transcrip-
tional activity. Together, these findings delineate a molecular
mechanism underlying the shift from oxidative to glycolytic
metabolism that is associated with the expression of PKM2 in
cancer cells. PKM2 also stimulates HIF-1/HIF-2-dependent
VEGF gene expression in hypoxic HeLa cells, suggesting that,
through its function as a HIF-1 coactivator, PKM2 may play a
far broader role in promoting cancer progression than has
been appreciated heretofore.
HIF-1a and HIF-2a were the first PHD3 substrates identified
(Epstein et al., 2001), although PHD3 is less active in mediating
HIF-1a hydroxylation than PHD2, which is the primary regulator
of HIF-1a hydroxylation and proteasomal degradation in well-742 Cell 145, 732–744, May 27, 2011 ª2011 Elsevier Inc.oxygenated cells (Berra et al., 2003). PHD3 was subsequently
shown to promote degradation of the b2-adrenergic receptor
(Xie et al., 2009) and the transcription factor ATF-4 (Ko¨ditz
et al., 2007). Two Pro residues in the b2-adrenergic receptor
were hydroxylated by PHD3 (Xie et al., 2009). Here, we identified
a putative PHD hydroxylation motif LRRLAP403 within the unique
exon 10 domain of PKM2. Hydroxylation of Pro-403 and Pro-408
in PKM2 was demonstrated by mass spectrometry. The pres-
ence of acidic (Asp/Glu) residues near the Pro residue appears
to be important for hydroxylation by PHD3 (Li et al., 2004; Xie
et al., 2009), and several acidic residues are present on either
side of Pro-403/408 (Figure S3A). Double mutation of Pro-403/
408 reduced PKM2 hydroxylation to a degree that was similar
to knockdown of PHD3 or exposure to near-anoxic conditions.
The similarity in the degree of PKM2 hydroxylation (as measured
by anti-Pro-OH antibody binding) in cells incubated at 20%
versus 1% O2 for 24 hr is due to the dramatic increase in
PHD3 protein levels under hypoxic conditions (Figure 5C), which
compensates for the reduction in hydroxylase activity. Quantita-
tive mass spectrometric data comparing the prolyl hydroxylation
of PKM2 in cells expressing or deficient in PHD3 cannot be
obtained because the relevant PKM2 tryptic peptide is subject
to multiple modifications in addition to prolyl hydroxylation
(data not shown). Nevertheless, experimental evidence pre-
sented above indicates that PKM2 is hydroxylated by PHD3.
Intratumoral hypoxia is commonly found in aggressive solid
cancers, leading toHIF-1aaccumulation (Harris, 2002;Semenza,
2003). However, HIF-1a is also highly expressed in well-oxygen-
ated cancer cells with loss of function of certain tumor suppres-
sors, most notably VHL (Melillo, 2007; Semenza, 2010). Although
HIF-1a accumulates in VHL null cells under aerobic conditions,
FIH-1-mediated hydroxylation of the HIF-1a transactivation
domain should block recruitment of p300 and inhibit transactiva-
tion. The interaction of PKM2 with HIF-1a and p300 may provide
a mechanism to bypass negative regulation by FIH-1. We have
shown that, in VHL null RCC4 cells, PKM2 promotes HIF-1 trans-
activation of target genes thatmediate increased glucose uptake
(GLUT1), increased lactate production (LDHA), and decreased
oxidative metabolism (PDK1). This coactivator function of
PKM2 provides a molecular mechanism by which it can act
with HIF-1 to reprogram glucose metabolism in cancer cells,
thus answering a major question regarding the role of PKM2 in
cancer progression (Figure 7H). Our data on PKM2 and previous
studies of the EGLN3 gene, which encodes PHD3 (Pescador
et al., 2005), indicate that PKM2 and EGLN3 are both direct
HIF-1 target genes, resulting in a positive feedback loop that
amplifies HIF-1 activity and may accelerate metabolic reprog-
ramming and other critical aspects of cancer progression that
are mediated by HIF-1 (Figure 7H).
EXPERIMENTAL PROCEDURES
Detailed procedures are described in the Extended Experimental Procedures.
Cell Culture and Transfection
HeLa, MEFs, RCC4, HEK293, HEK293T, and Hep3B cells were cultured
in DMEM with 10% heat-inactivated FBS and 1 mM sodium pyruvate and
1% nonessential amino acid (MEFs only) at 37C in a 5% CO2/95% air incu-
bator. Hypoxic cells (1% O2) were placed in a modular incubator chamber
(Billups-Rothenberg). Anoxic cells (<0.1% O2) were placed in a controlled
atmosphere chamber (Plas-Labs). Cells were transfected using Fugene-6
(Roche), Lipofectamine 2000 (Invitrogen), or PolyJet (SignaGen).
Virus Production
shSC, shNT, shPKM2, or shPHD3 retrovirus or lentivirus was generated by
transfection of HEK293T cells with transducing vector and packaging vectors
pMD.G and pNGVL3-gag/pol (for retrovirus) or pCMVR8.91 (for lentivirus).
After 48 hr, virus particles in the medium were harvested, filtered, and trans-
duced into HeLa or RCC4 cells.
In Vitro Binding Assays
GST fusion proteins were expressed in E. coli BL21-Gold (DE3) and purified.
Mammalian cells were lysed in RIPA buffer. Co-IP, GST pull-down, and
immunoblot assays were performed as described (Luo et al., 2010).
In Vitro Hydroxylation Assays
The immobilized GST-E10 protein was incubated at 30C for 1 hr with
HEK293T cell lysates supplemented with 100 mM FeCl2, 5 mM ascorbate,
and 1 mM a-ketoglutarate and was washed, fractionated by SDS-PAGE,
and stained with colloidal blue staining kit (Invitrogen). GST-E10 protein was
digested in-gel with trypsin, and the tryptic peptides were analyzed by LTQ
Orbitrap Velos mass spectrometry (Thermo Scientific).
Subcellular Fractionation
HeLa cells were lysed in hypotonic buffer by a Dounce homogenizer
(40 strokes). Intact cells were removed by centrifugation at 53 3 g for
10 min. The nuclei were collected by centrifugation at 800 3 g for 10 min,
washed, and lysed in isotonic buffer by sonication. The supernatant was taken
as the cytosolic fraction.
Luciferase Reporter Assays
Cells were seeded onto 48-well plates, transfected with p2.1 reporter
(Semenza et al., 1996), PKM2 HRE reporter, or GalA/GalO (Jiang et al.,
1997) and reporter plasmid pG5E1bLuc; control reporter pSV-Renilla; together
with PKM2, PKM1, PHD3, or PHD2 expression vector, and exposed to 20%
or 1% O2 for 24 hr. FLuc and RLuc activities were determined using the
Dual-Luciferase Assay System (Promega).
qRT-PCR
Total RNA was isolated using Trizol (Invitrogen) and reverse-transcribed.
qRT-PCR assays were performed as described (Fukuda et al., 2007). Primer
sequences are listed in Table S1.
ChIP Assays
ChIP assays were performed using ChIP Assay Kit (Upstate). HeLa cells were
crosslinked with 1% formaldehyde for 20 min at 37C and quenched in
0.125 M glycine. DNA was immunoprecipitated from the sonicated cell lysates
and quantified using SYBR Green Real-time PCR analysis (Bio-Rad). Primer
sequences are listed in Table S1. Fold enrichment was calculated based on
Ct as 2D(DCt), where DCt = CtIP - CtInput and D(DCt) = DCtantibody - DCtIgG.
Metabolism Assays
RCC4 cells were transduced with retrovirus encoding shSC or shPHD3-704 or
with lentivirus encoding shNT or shPHD3-766. The intracellular glucose was
measured in the cell lysates with glucose assay kit (BioVision). The extracel-
lular lactate was measured in the medium with lactate assay kit (BioVision).
The OCR was measured using a cartridge containing an optical fluorescent
O2 sensor in a Seahorse Bioscience XF24 Extracellular Flux Analyzer.
Statistical Analysis
Data were expressed as mean ± SEM. Differences were examined by
Student’s t test between two groups or one-way analysis of variance within
multiple groups.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures,
six figures, and one table and can be found with this article online at
doi:10.1016/j.cell.2011.03.054.
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